These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36017864)

  • 1. Fundamentals and Applications of Isolated Perfused Lung (IPL) Model in the Development of Pulmonary Drug Delivery.
    Mireskandari K; Ardakani YH; Moghadam ES; Ketabchi F; Rouini M
    Curr Drug Deliv; 2023; 20(10):1425-1440. PubMed ID: 36017864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical.
    Selg E; Acevedo F; Nybom R; Blomgren B; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):273-84. PubMed ID: 20455769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.
    Selg E; Ewing P; Acevedo F; Sjöberg CO; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):181-9. PubMed ID: 23094685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption.
    Eriksson J; Sjögren E; Lennernäs H; Thörn H
    AAPS J; 2020 May; 22(3):71. PubMed ID: 32394314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling.
    Eriksson J; Thörn H; Lennernäs H; Sjögren E
    Eur J Pharm Biopharm; 2020 Nov; 156():191-202. PubMed ID: 32941997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
    Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
    Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of models for the evaluation of pulmonary drug disposition.
    Liu X; Jin L; Upham JW; Roberts MS
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):487-505. PubMed ID: 23294005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in inhaled product development and opportunities for open innovation.
    Forbes B; Asgharian B; Dailey LA; Ferguson D; Gerde P; Gumbleton M; Gustavsson L; Hardy C; Hassall D; Jones R; Lock R; Maas J; McGovern T; Pitcairn GR; Somers G; Wolff RK
    Adv Drug Deliv Rev; 2011; 63(1-2):69-87. PubMed ID: 21144875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs.
    Matera MG; Calzetta L; Ora J; Rogliani P; Cazzola M
    Expert Opin Drug Deliv; 2021 Jul; 18(7):891-906. PubMed ID: 33412922
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
    Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
    Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respirable aerosol exposures of nicotine dry powder formulations to
    Sciuscio D; Hoeng J; Peitsch MC; Vanscheeuwijck P
    Inhal Toxicol; 2019 May; 31(6):248-257. PubMed ID: 31496314
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.
    Tolman JA; Williams RO
    Drug Dev Ind Pharm; 2010 Jan; 36(1):1-30. PubMed ID: 19640248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis.
    Eriksson J; Sjögren E; Thörn H; Rubin K; Bäckman P; Lennernäs H
    Eur J Pharm Biopharm; 2018 Mar; 124():1-12. PubMed ID: 29191716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
    Wang YB; Watts AB; Peters JI; Williams RO
    Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Formulation Development for Inhaled Pharmaceuticals.
    Sou T; Bergström CAS
    J Pharm Sci; 2021 Jan; 110(1):66-86. PubMed ID: 32916138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of inhaled drugs.
    Lipworth BJ
    Br J Clin Pharmacol; 1996 Dec; 42(6):697-705. PubMed ID: 8971424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitask learning for predicting pulmonary absorption of chemicals.
    Chiu YW; Tung CW; Wang CC
    Food Chem Toxicol; 2024 Mar; 185():114453. PubMed ID: 38244667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.